PPT-Monitoring N-acetyl-aspartate (NAA) in Patients with Spontaneous Intracerebral Hemorrhage
Author : QueenBee | Published Date : 2022-08-01
Wendy C Ziai MD MPH FAHA Johns Hopkins Medical Institutions Division of Neurocritical Care Baltimore MD USA June 2 2017 2 October 14 2013 ANA 2013 Presenter Disclosure
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "Monitoring N-acetyl-aspartate (NAA) in P..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Monitoring N-acetyl-aspartate (NAA) in Patients with Spontaneous Intracerebral Hemorrhage: Transcript
Wendy C Ziai MD MPH FAHA Johns Hopkins Medical Institutions Division of Neurocritical Care Baltimore MD USA June 2 2017 2 October 14 2013 ANA 2013 Presenter Disclosure Information FINANCIAL DISCLOSURE. Ngo Minh . Triet. , MD. Department of Neurology, . University of Medicine and Pharmacy. Introduction. Intracerebral. . hemorrhage (ICH) results from the rupture of an . intracerebral. vessel. .. 10-35% percent of all strokes (in USA). . Hemorrhagic stroke vs. ischemic stroke. Intracerebral hemorrhage. Occurs from rupture of cerebral vessels . Can be a result of high blood pressure. Ischemic Stroke. . Caused by the development of a thrombus and/or embolus. Fred V. Plapp MD PhD. Pathology and Laboratory Medicine. Kansas University Medical Center. Financial Disclosure. Educational Objectives. Discuss intracerebral hemorrhage prevalence and etiologies. Review anticoagulation by warfarin and anti-Factor . Rhonda Finnie, DNP, APRN, AGACNP-BC, ANVP-BC. Baptist Health Neurosurgery Arkansas – Baptist Health Neurology. Stroke Symposium. October 26, 2017. I have no disclosures. …. Identify risk factors, etiology, and clinical features associated with intracerebral hemorrhage. ICH. MECHANISMS OF INTRACEREBRAL. HEMORRHAGE:. Hypertension . Vascular Malformation s . Intracranial . Tumors . Bleeding Disorders, . Antico. . agulants. , and . Fibrinolytic. Treatment . Cerebral Amyloid . Pathophysiological. . Facts :. For maintained normal brain function :. Continuous blood flow-15% of cardiac output. High oxygen requirement- 20% of total body O2 consumption . Maintenance of glucose. Authors. : Curado, S . X. ; . K. niggendorf. , V . F. ; . K. niggendorf. . S. L; . J. unior, I . R. . M; . Ugarte. , M F S. INTRODUCTION. . CASE REPORT . DISCUSSION . REFERENCES . Pathological . myopia was originally described as myopia, associated . 69 lymphoma: A case report and literature review * 1 Ji-Qing Qiu PhD , * 2 Yu Cui MD , 3 Li-Chao Sun MD , 1 Bin Qi PhD , 1 Zhan-Peng Zhu PhD *JQ Qiu and Y Cui contributed equally to this work Brain Abscess Following Intracerebral Hemorrhage: A Case ReportJin Kyung Oh, M.D., Young Joo Kim, M.D., Eun Deok Chang, M.D. Tel. 82-31-820-3599 Fax. 82-31-846-3080 E-mail: violet2@catholic.ac.kr Figure 1. Plain cranial CT scan upon initial consult showing bilateral lobar haemorrhage. Figure 2. Chest x-ray upon initial consult. Figure 3. CT angiography of patient done at hospital day 2 showing Case Report AbstractKeywords: Obstructive Hydrocephalus; Subarachnoid Hemorrhage; Intraventricular Hemorrhage Received: March 28, 2020 Figure 1: a, b: brain CT without a contract in axial cut shows S Content. : . Vineeta. Singh, MD; Craig Williamson, MD; Jennifer . Erklauer. , MD. Slides. : Nicholas A. Morris, MD. Presenter:. Your name. Your institution. . . . . Conflicts:. No conflicts. Intracerebral. hemorrhage . accounts for . 8-13% . of all strokes and results from a wide spectrum . of disorders, . is more likely to result in death than ischemic stroke.. . Intracerebral. hemorrhage and accompanying edema may disrupt or compress adjacent brain tissue, leading to neurological dysfunction. Substantial . S. urvivors for Stroke . P. revent. I. on. and . RE. covery. Mean reduction of 9/4 mm Hg. Of course you want to join the first ICH prevention study – . ASPIRE. – in recent NIH history! . This is a great trial to contribute to an active clinical practice question and a wonderful way to build out your StrokeNet trial portfolio!.
Download Document
Here is the link to download the presentation.
"Monitoring N-acetyl-aspartate (NAA) in Patients with Spontaneous Intracerebral Hemorrhage"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents